InsiderClue
Insiders · Profile

Henderson Jeffrey William

Director at HALOZYME THERAPEUTICS · Director at Becton Dickinson · Director at KYNTRA BIO · and 2 more. Filing since 26 Apr 2011. CIK 0001324015

HALO HALOZYME THERAPEUTICS, INC. Director · 8 trades BDX Becton Dickinson Director · 1 trade KYNB KYNTRA BIO, INC. Director · 4 trades QCOM Qualcomm Director · 3 trades CAH Cardinal Health Chief Financial Officer · 17 trades
Company
Date
Role
Action
Shares
Amount
Of holding
HALO HALOZYME THERAPEUTICS, INC.
28 Apr 2025
Director
Sold on a plan
4,497
$271.47K
13.6%
HALO HALOZYME THERAPEUTICS, INC.
1 Apr 2025
Director
Sold on a plan
503
$32.22K
1.5%
HALO HALOZYME THERAPEUTICS, INC.
3 Mar 2025
Director
Sold on a plan
5,000
$293.46K
12.9%
BDX Becton Dickinson
10 Feb 2025
Director
Bought
1,500
$350.43K
23.0%
HALO HALOZYME THERAPEUTICS, INC.
3 Feb 2025
Director
Sold on a plan
5,000
$281.52K
11.5%
HALO HALOZYME THERAPEUTICS, INC.
6 Jan 2025
Director
Sold on a plan
10,000
$500.06K
18.7%
KYNB KYNTRA BIO, INC.
1 Sep 2023
Director
Sold on a plan
2,000
$2.06K
6.5%
KYNB KYNTRA BIO, INC.
4 Aug 2023
Director
Sold on a plan
2,000
$3.82K
6.1%
KYNB KYNTRA BIO, INC.
11 Jul 2023
Director
Sold on a plan
2,000
$5.38K
5.7%
KYNB KYNTRA BIO, INC.
8 Jun 2023
Director
Sold on a plan
7,000
$122.19K
16.7%
HALO HALOZYME THERAPEUTICS, INC.
1 Mar 2023
Director
Sold, plan not stated
10,000
$477.10K
20.4%
HALO HALOZYME THERAPEUTICS, INC.
28 Feb 2023
Director
Sold, plan not stated
10,000
$485.10K
16.9%
QCOM Qualcomm
23 Feb 2023
Director
Sold, plan not stated
2,500
$310.47K
54.3%
QCOM Qualcomm
22 Feb 2023
Director
Sold, plan not stated
2,500
$310.13K
35.2%
HALO HALOZYME THERAPEUTICS, INC.
25 Nov 2020
Director
Sold, plan not stated
24,498
$981.76K
34.0%
QCOM Qualcomm
10 Nov 2020
Director
Sold, plan not stated
6,000
$846.60K
83.2%
CAH Cardinal Health
27 Aug 2014
Chief Financial Officer
Sold, plan not stated
26,567
$1.93M
28.3%
CAH Cardinal Health
18 Aug 2014
Chief Financial Officer
Sold, plan not stated
78,637
$5.67M
53.9%
CAH Cardinal Health
8 Aug 2014
Chief Financial Officer
Sold, plan not stated
118,093
$8.23M
61.8%
CAH Cardinal Health
14 Jul 2014
Chief Financial Officer
Sold, plan not stated
23,632
$1.67M
22.1%
CAH Cardinal Health
7 May 2014
Chief Financial Officer
Sold, plan not stated
27,031
$1.73M
20.2%
CAH Cardinal Health
3 Feb 2014
Chief Financial Officer
Sold, plan not stated
253,190
$17.01M
65.4%
CAH Cardinal Health
13 Aug 2013
Chief Financial Officer
Sold, plan not stated
54,590
$2.84M
24.6%
CAH Cardinal Health
26 Jul 2013
Chief Financial Officer
Sold, plan not stated
76,781
$3.92M
33.1%
CAH Cardinal Health
18 Jul 2013
Chief Financial Officer
Sold, plan not stated
57,623
$2.88M
30.4%
CAH Cardinal Health
15 Jul 2013
Chief Financial Officer
Sold, plan not stated
14,660
$732.85K
10.1%
CAH Cardinal Health
11 Jul 2013
Chief Financial Officer
Sold, plan not stated
83,211
$4.08M
38.9%
CAH Cardinal Health
6 May 2013
Chief Financial Officer
Sold, plan not stated
207,918
$9.60M
65.9%
CAH Cardinal Health
4 Oct 2012
Chief Financial Officer
Sold, plan not stated
46,226
$1.85M
29.6%
CAH Cardinal Health
10 Sep 2012
Chief Financial Officer
Sold, plan not stated
77,081
$2.95M
41.1%
CAH Cardinal Health
7 Sep 2012
Chief Financial Officer
Sold, plan not stated
2,329
$91.74K
100%
CAH Cardinal Health
19 May 2011
Chief Financial Officer
Sold, plan not stated
57,854
$2.62M
34.5%
CAH Cardinal Health
26 Apr 2011
Chief Financial Officer
Sold, plan not stated
59,035
$2.54M
32.9%
33 decisions on file.